People-oriented, pursuit of excellence, win-win development, future-oriented

On October 28, Sinopod Xinguang Medical Technology Co., LTD. (hereinafter referred to as "Sinopod Xinguang") and Jiangsu Anxin Medical Technology Co., LTD. (hereinafter referred to as "Anxin Medical") signed a strategic cooperation agreement in Beijing. Wang Changdong, General manager of Sinopod Xinguang, Yang Yang, general manager of Anxin Medical signed the agreement on behalf of both parties, Qin Qi, deputy general manager of Sinopod Xinguang, Tian Xiaofen, head of the Marketing Department, Anxin Medical Technical Director Wang Feng, sales manager Zhou Hong, and relevant personnel from both sides attended the signing ceremony.

During the discussion, Wang Changdong, general manager of Sinopharm Xinguang, warmly welcomed the arrival of Anxin medical leaders and introduced the company's research and development, production, quality management, product marketing, etc., he said that endoscopic stapler as one of the mainstream varieties of minimally invasive surgery, a wide range of applications, market demand is large, in recent years, China's endoscopic stapler industry has developed rapidly. Independent research and development capabilities and innovation capabilities continue to improve, I hope that the teams of both sides will give full play to their technological advantages, brand advantages and channel advantages to promote deeper and more solid cooperation, work together to cultivate new quality productivity, and contribute to the innovation and development of domestic high-end medical products.

Yang Yang, general manager of Anxin Medical, said that he hopes to take this signing as an opportunity to strengthen cooperation with Sinopharm Xinguang in a wider range and more areas, deepen synergy in the industrial chain and supply chain, further expand competitive advantages, market share and influence, and jointly promote the high-quality development of China's high-end medical industry.